معرفی
Dmitry Antonov is a Researcher at Uppsala University's Department of Medicinal Chemistry; Drug Design and Discovery. His work focuses on the development of novel antimicrobial agents targeting Gram-negative bacterial pathogenesis.
- Current role: Researcher in Medicinal Chemistry
- Key research areas: Antibiotic development, Lipopolysaccharide Synthesis, In Vivo Pharmacology
Recent research highlights include a 2024 publication in Proceedings of the National Academy of Sciences proposing a new antibiotic class targeting cell wall synthesis in Gram-negative pathogens. This work has garnered significant attention across academic and lay platforms.
۰مقاله منتشرشده
